JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB75898

Anti-Brd4 antibody

4

(4 Reviews)

|

(32 Publications)

Rabbit Polyclonal BRD4 antibody. Suitable for WB, ICC/IF and reacts with Mouse, Rat, Human samples. Cited in 32 publications.

View Alternative Names

HUNK1, BRD4, Bromodomain-containing protein 4, Protein HUNK1

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-Brd4 antibody (AB75898)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Brd4 antibody (AB75898)

ICC/IF image of ab75898 stained MCF7 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab75898, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 4% PFA fixed (10 min) HeLa, Hek293 and HepG2 cells at 5µg/ml.

Western blot - Anti-Brd4 antibody (AB75898)
  • WB

Unknown

Western blot - Anti-Brd4 antibody (AB75898)

All lanes:

Western blot - Anti-Brd4 antibody (ab75898) at 1 µg/mL

Lane 1:

Liver (Mouse) Tissue Lysate at 10 µg/mL

Lane 2:

Liver (Rat) Tissue Lysate at 10 µg/mL

Lane 3:

Human liver tissue lysate - total protein (<a href='/en-us/products/unavailable/human-liver-tissue-lysate-total-protein-ab29889'>ab29889</a>) at 10 µg/mL

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP)

Predicted band size: 152 kDa

Observed band size: 171 kDa,70 kDa

true

Exposure time: 150s

Western blot - Anti-Brd4 antibody (AB75898)
  • WB

Lab

Western blot - Anti-Brd4 antibody (AB75898)

Lanes 1 - 2 : Merged signal (red and green). Green - ab75898 observed at 220 kDa. Red - loading control Mouse anti Vinculin observed at 125 kDa.

ab75898 was shown to react with Brd4 in HAP1 wild-type cells in Western blot with loss of signal observed in BRD4 knockout sample. Wild-type HAP1 and BRD4 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab75898 and Mouse anti Vinculin overnight at 4 °C at 1 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-Brd4 antibody (ab75898) at 1 µg/mL

Lane 1:

Wild-type HAP1 cell lysate at 20 µg

Lane 2:

BRD4 knockout HAP1 cell lysate at 20 µg

Predicted band size: 152 kDa

Observed band size: 220 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-Brd4 antibody (AB75898)
  • ICC/IF

AbReview27967****

Immunocytochemistry/ Immunofluorescence - Anti-Brd4 antibody (AB75898)

ab75898 (1/500) staining Brd4 in HeLa cells (green). Cells were fixed in paraformaldehyde, permeabilized with 0.5% Triton X-100/PBS and counterstained with DAPI in order to highlight the nucleus (red). For further experimental details please refer to Abreview.

Image courtesy of an Abreview submitted by Dr. Kirk McManus, Univ. of Manitoba/Cancer Care MICB, Canada

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Dog": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Horse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

"Note: Batches of this product that have a concentration < 1mg/ml may have BSA added as a stabilising agent. If you would like information about the formulation of a specific lot, please contact our scientific support team who will be happy to help."

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Brd4 protein also known as Bromodomain containing protein 4 plays an important role as a transcriptional regulator. It recognizes acetylated lysine residues on histone tails through its bromodomains. This binding impacts chromatin structure and transcriptional activation. The Brd4 protein has a molecular weight of around 150 kDa and is often used as a marker in studies using Brd4 western blot techniques. It mainly expresses in the nucleus of most cell types and is an important focus for developing Brd4 anticuerpos useful for detecting protein size discrepancies in research.
Biological function summary

Brd4 plays a significant role in regulating gene expression during cell cycle progression. It interacts with the Mediator complex enabling communication between transcriptional activators and RNA polymerase II. This protein is integral for maintaining chromatin in an active state ensuring accessibility for transcription machinery. Moreover Brd4 size and functionality relate to the elongation of transcription by RNA polymerase II ensuring the seamless expression of genes essential for cellular functions.

Pathways

Brd4 integrates into transcriptional and epigenetic regulation pathways. It acts in the positive regulation of the MYC pathway directly linking Brd4 with proto-oncogene c-Myc. Also Brd4 engages in the JAK/STAT signaling pathway where its activity affects cell growth and immune response. These interactions establish Brd4 as a central regulator within these pathways facilitating communication and coordination among molecular players.

Brd4 link heavily to cancer and inflammatory diseases. Aberrant Brd4 activity often associates with various cancers including leukemia where its regulation impacts oncogenic drivers. Clinically targeting Brd4 presents a therapeutic avenue as its inhibition affects cyclin-dependent kinase 9 (CDK9) an important regulator of the cell cycle. Similarly Brd4 alterations implicate in inflammatory disorders impacting nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling revealing pathways for intervening in pathogenic processes.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Chromatin reader protein that recognizes and binds acetylated histones and plays a key role in transmission of epigenetic memory across cell divisions and transcription regulation (PubMed : 20871596, PubMed : 23086925, PubMed : 23317504, PubMed : 29176719, PubMed : 29379197). Remains associated with acetylated chromatin throughout the entire cell cycle and provides epigenetic memory for postmitotic G1 gene transcription by preserving acetylated chromatin status and maintaining high-order chromatin structure (PubMed : 22334664, PubMed : 23317504, PubMed : 23589332). During interphase, plays a key role in regulating the transcription of signal-inducible genes by associating with the P-TEFb complex and recruiting it to promoters (PubMed : 16109376, PubMed : 16109377, PubMed : 19596240, PubMed : 23589332, PubMed : 24360279). Also recruits P-TEFb complex to distal enhancers, so called anti-pause enhancers in collaboration with JMJD6 (PubMed : 16109376, PubMed : 16109377, PubMed : 19596240, PubMed : 23589332, PubMed : 24360279). BRD4 and JMJD6 are required to form the transcriptionally active P-TEFb complex by displacing negative regulators such as HEXIM1 and 7SKsnRNA complex from P-TEFb, thereby transforming it into an active form that can then phosphorylate the C-terminal domain (CTD) of RNA polymerase II (PubMed : 16109376, PubMed : 16109377, PubMed : 19596240, PubMed : 23589332, PubMed : 24360279). Regulates differentiation of naive CD4(+) T-cells into T-helper Th17 by promoting recruitment of P-TEFb to promoters (By similarity). Promotes phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II (PubMed : 23086925). According to a report, directly acts as an atypical protein kinase and mediates phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II; these data however need additional evidences in vivo (PubMed : 22509028). In addition to acetylated histones, also recognizes and binds acetylated RELA, leading to further recruitment of the P-TEFb complex and subsequent activation of NF-kappa-B (PubMed : 19103749). Also acts as a regulator of p53/TP53-mediated transcription : following phosphorylation by CK2, recruited to p53/TP53 specific target promoters (PubMed : 23317504).. Isoform B. Acts as a chromatin insulator in the DNA damage response pathway. Inhibits DNA damage response signaling by recruiting the condensin-2 complex to acetylated histones, leading to chromatin structure remodeling, insulating the region from DNA damage response by limiting spreading of histone H2AX/H2A.x phosphorylation.
See full target information BRD4

Publications (32)

Recent publications for all applications. Explore the full list and refine your search

Journal of translational medicine 21:752 PubMed37880710

2023

JMJD6-BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ruifeng Pei,Le Zhao,Yiren Ding,Zhan Su,Deqiang Li,Shuo Zhu,Lu Xu,Wei Zhao,Wuyuan Zhou

Cell death discovery 9:279 PubMed37528096

2023

Bellidifolin ameliorates isoprenaline-induced cardiac hypertrophy by the Nox4/ROS signalling pathway through inhibiting BRD4.

Applications

Unspecified application

Species

Unspecified reactive species

Dingyan Zhou,Weizhe Liu,Juanjuan Zhang,Yucui Dong,Jiangli Wu,Yu Zhang,Cheng Dai,Tingting Zhang,Gaoshan Yang,Yue Zhang,Aiying Li

NPJ precision oncology 7:11 PubMed36693944

2023

Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

S M Nashir Udden,GuemHee Baek,Kamal Pandey,Chantal Vidal,Yulun Liu,Asal S Rahimi,D Nathan Kim,Chika R Nwachukwu,Ram S Mani,Prasanna G Alluri

Stem cell research & therapy 13:340 PubMed35883157

2022

Pretreatment of nucleus pulposus mesenchymal stem cells with appropriate concentration of HO enhances their ability to treat intervertebral disc degeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Yao Zhang,Zhi-Lei Hu,Yu-Han Qi,Hai-Yin Li,Xian Chang,Xiao-Xin Gao,Chen-Hao Liu,Yue-Yang Li,Jin-Hui Lou,Yu Zhai,Chang-Qing Li

Journal of cardiovascular pharmacology 78:839-846 PubMed34524258

2021

BRD4 Inhibition Protects Against Myocardial Ischemia/Reperfusion Injury by Suppressing Inflammation and Oxidative Stress Through the PI3K/AKT Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hongwei Wei,Qingjian Xue,Lei Sun,Jie Lv

Nucleic acids research 49:6281-6295 PubMed34107030

2021

The H3K36me2 methyltransferase NSD1 modulates H3K27ac at active enhancers to safeguard gene expression.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Fang,Yin Tang,Yanjun Zhang,Yixin Pan,Junqi Jia,Zhongxing Sun,Weiwu Zeng,Jiaqi Chen,Ying Yuan,Dong Fang

Autophagy 18:391-408 PubMed34074211

2021

Epigenetic reader BRD4 supports mycobacterial pathogenesis by co-modulating host lipophagy and angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Tanushree Mukherjee,Bharat Bhatt,Praveen Prakhar,Gaurav Kumar Lohia,R S Rajmani,Kithiganahalli Narayanaswamy Balaji

Cell death & disease 12:530 PubMed34031359

2021

Pericentromeric Satellite III transcripts induce etoposide resistance.

Applications

Unspecified application

Species

Unspecified reactive species

Julian Kanne,Michelle Hussong,Jörg Isensee,Álvaro Muñoz-López,Jan Wolffgramm,Felix Heß,Christina Grimm,Sergey Bessonov,Lydia Meder,Jie Wang,H Christian Reinhardt,Margarete Odenthal,Tim Hucho,Reinhard Büttner,Daniel Summerer,Michal R Schweiger

International journal of chronic obstructive pulmonary disease 16:919-931 PubMed33854310

2021

Circ-OSBPL2 Contributes to Smoke-Related Chronic Obstructive Pulmonary Disease by Targeting miR-193a-5p/BRD4 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Caifen Zheng,Yongping Zhang,Yingchun Zhao,Yuanfang Duan,Qianghua Mu,Xinying Wang

Molecular medicine reports 19:5227-5236 PubMed31059052

2019

miR‑125b‑mediated regulation of cell proliferation through the Jagged‑1/Notch signaling pathway by inhibiting BRD4 expression in psoriasis.

Applications

Unspecified application

Species

Unspecified reactive species

Min Pan,Yao Huang,Xiaofang Zhu,Xiangfei Lin,Dan Luo
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com